ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 19 filers reported holding ANI PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $17,674,000 | -11.5% | 16,403,000 | 0.0% | 0.01% | -11.1% |
| Q2 2019 | $19,981,000 | +46.2% | 16,403,000 | +32.3% | 0.01% | +28.6% |
| Q1 2019 | $13,663,000 | +32.5% | 12,403,000 | +21.1% | 0.01% | +16.7% |
| Q4 2018 | $10,314,000 | -13.6% | 10,241,000 | -8.9% | 0.01% | +20.0% |
| Q3 2018 | $11,933,000 | +20.5% | 11,241,000 | +28.6% | 0.01% | 0.0% |
| Q2 2018 | $9,906,000 | +3.1% | 8,741,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $9,604,000 | +76.4% | 8,741,000 | +74.8% | 0.01% | -16.7% |
| Q2 2016 | $5,443,000 | -44.4% | 5,000,000 | -50.0% | 0.01% | -45.5% |
| Q4 2015 | $9,790,000 | +4.7% | 10,000,000 | 0.0% | 0.01% | +22.2% |
| Q3 2015 | $9,354,000 | -46.5% | 10,000,000 | -34.5% | 0.01% | -40.0% |
| Q2 2015 | $17,495,000 | -23.8% | 15,270,000 | -23.6% | 0.02% | -31.8% |
| Q1 2015 | $22,966,000 | -8.6% | 20,000,000 | -16.7% | 0.02% | -12.0% |
| Q4 2014 | $25,140,000 | – | 24,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 59,455 | $68,522,000 | 3.54% |
| DLD Asset Management, LP | 4,500,000 | $5,185,000 | 1.70% |
| Worth Venture Partners, LLC | 945,000 | $1,100,000 | 1.18% |
| Perceptive Advisors | 7,500,000 | $8,700,000 | 0.62% |
| WOLVERINE ASSET MANAGEMENT LLC | 15,439,000 | $17,789,000 | 0.23% |
| Allianz Asset Management GmbH | 35,165,000 | $40,795,000 | 0.04% |
| GABELLI FUNDS LLC | 1,500,000 | $1,740,000 | 0.01% |
| AQR Arbitrage LLC | 525,000 | $605,000 | 0.01% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 9,000,000 | $10,328,000 | 0.01% |
| Edge Advisors, LLC | 33,000 | $38,000 | 0.01% |